2022-Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary seriesvaccination

Kessaya Waidee

Publications : 0
Followers : 0

Chatsiricharoenkul S, Niyomnaitham S, Posen HJ, Toh ZQ, Licciardi PV,Wongprompitak P, Duangchinda T, Pakchotanon P, Chantima W, Chokephaibulkit K. Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary seriesvaccination. Front Immunol. (Frontiers in Immunology) 2022 ;13:1010835

Like this book? You can publish your book online for free in a few minutes!

Create your own flipbook

View Text Version Likes : 0
Category : All Report

Follow
Upload
0
Embed
Share

2022-Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary seriesvaccination